Chronic Use of Ranitidine and Gastrointestinal Malignancies Chronic Use of Ranitidine and Gastrointestinal Malignancies

Unacceptable levels of NDMA in ranitidine caused it to be removed it from the market. Do patients who took ranitidine have a higher risk of GI cancer compared with those on other anti-reflux drugs?Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news